IP Library › Granted Patent US 10,022,543
Granted Patent B2
US 10,022,543 · App. 13/144,277 · Granted Jul 17, 2018

Cell stimulation using quantum dots

Inventor: Jefferey Olson (Cherry Hills, CO)
Assignee: The Regents of the University of Colorado, a body corporate
A61N1/36046A61N1/3787A61N5/0603A61N5/0622B82Y15/00B82Y30/00A61N2005/0659
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,022,543
App. No.
13/144,277
Granted
Jul 17, 2018
Kind
B2
Abstract

The present invention provides methods for stimulating cells using quantum dots. In addition, the present invention provides methods for treating a variety of clinical conditions using stimulation of quantum dots to induce cell stimulation and/or function.

Claims (10)

1. A method for providing a subject with endogenous night vision, the method comprising:

providing a quantum dot to the subject not experiencing or displaying symptoms of visual impairment, wherein the subject comprises a retina and the retina comprises a retinal cell;

wherein the quantum dot emits a local field charge in response to exclusively infrared radiation emitted by an object and not in response to wavelengths of light within the visible spectrum of light;

providing a bio-targeted material to localize the quantum dot proximal to the retinal cell; and

exposing the retina to infrared radiation, wherein the local field charge emitted by the quantum dot results in an action potential;

wherein the action potential results in a visual response; and

wherein the visual response provides the subject with endogenous night vision, allowing the subject comprising the retina to visualize the object in an environment without visible illumination.

2. The method of claim 1 , wherein the quantum dot is coated with the bio-targeted material.

3. The method of claim 2 , wherein the bio-targeted material is biotin or streptavadin.

4. The method of claim 1 , wherein the quantum dot is not photoluminescent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2012
From: OLSON, JEFFEREY
To: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
Reel/Frame 029236/0716 →
Continuity (2)
Provisional Application 61144155 · Jan 13, 2009
Related Publication 20110270153A1 · Nov 3, 2011